USzyme 疟疾诊断免疫层析试纸条

🦠 USzyme Malaria Diagnostic Rapid Test Strips (Immunochromatographic Assays)

🌐 HS Code Reference & Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition & Classification: Do You Really Understand "Malaria Rapid Tests"?

USzyme Malaria Diagnostic Rapid Test Strips are point-of-care (POC) in vitro diagnostic devices used to detect specific Plasmodium antigens (such as HRP-2, pLDH, or Aldolase) in human blood samples. In international trade, they are primarily classified under Chapter 30 (Pharmaceutical Products) or Chapter 90 (Optical, Photographic, Cinematographic, Measuring, Checking, Precision, Medical or Surgical Instruments and Apparatus), depending on their regulatory status and technical composition.

Key Distinction: * IVD Devices (In Vitro Diagnostics): If the product is registered/recognized as a medical device for diagnostic purposes (even if intended for over-the-counter use), it generally falls under Chapter 90. * Reagents/Kits: If classified as a chemical reagent kit not specifically designed as a medical instrument, it might fall under Chapter 30 or Chapter 38, but this is increasingly rare for modern rapid test strips in major markets like the US.

⚠️ Critical Classification Point:
- If the test strip is a finished medical device (sterile, single-use, labeled for diagnostic use) → HS 9018.90 or 9018.49
- If it is a chemical reagent (not strictly a medical device) → HS 3822.00 or 3006.90
- Most US FDA-cleared USzyme tests are classified under HS 9018.90 or 9018.49.

📦 II. HS Code Classification Details (2026 Latest Tariff Authority Comparison)

🔍 Key Reminder:
- USzyme tests are typically FDA 510(k) cleared as Class II Medical Devices. Therefore, HS 9018.90.80.00 is the correct and most common classification.
- If the product is labeled "For Research Use Only (RUO)", it may be classified under HS 3822.00.60.00 or 3822.00.80.00.
- Do not classify as "Pharmaceuticals" (Chapter 30) unless it is a reagent kit without device characteristics.

💰 III. 2026 Latest Tariff Rate Breakdown (Including Additional Taxes, Policy Surcharges)

✅ Applicable Country: United States (US)
✅ Country of Origin: China (CN) (Note: USzyme is manufactured by Hangzhou Junade Biotechnology Co., Ltd., China)
✅ Effective Date: November 10, 2025 onwards (including subsequent imports)

🎯 1. 9018.90.80.00 —— Other Medical Instruments (Malaria Rapid Tests)

📌 Explanation:
- "USITC Additional Tax 25%": Comes from the Section 301 tariffs on Chinese imports.
- "IEEPA 10%": The International Emergency Economic Powers Act tariff on Chinese goods.
- Total 35%: This is a high tariff rate. It is crucial to verify if the product qualifies for any exclusions (e.g., FDA-allowed medical supplies may have had previous exclusions, but check current status for 2026).

🎯 2. 3822.00.60.00 —— Diagnostic/Laboratory Reagents on Backing (RUO)

📌 Note:
- If declared as RUO (Research Use Only), the tariff rate is the same as medical devices due to Section 301 and IEEPA.
- No tariff advantage for RUO vs. Medical Device in this context.

🛠️ IV. Clearance Practical Advice (Battle-Tested Pitfall Avoidance Guide)

✅ 1. Document Checklist (All Required)

✅ 2. Declaration Tips (Key Mantra)

🔥 "Declare as IVD, Not as Chemical; Specify Antigen, Avoid Confusion!"

✅ 3. Special Situations

🌍 V. Global Market Clearance Comparison (2026 Latest)

📌 Conclusion:
- The US is the most tariff-challenged market for Chinese-made malaria RDTs due to 35% effective rate.
- EU and UK offer 0% tariffs but have strict IVDR/UKCA requirements.
- China domestic market has no tariffs but requires NMPA registration.

📌 VI. Common Errors & Pitfall Guide (Blood, Sweat, and Tears)

❌ Error 1: Declaring as "Chemical Reagent" (HS 3822) when it is an FDA-cleared Medical Device (HS 9018)
👉 Consequence: FDA may reject shipment for lacking device registration; customs may reclassify and apply 35% tariff.

❌ Error 2: Omitting "Malaria" or "Plasmodium" in description
👉 Consequence: Customs cannot verify duty rate; leads to inspection delay and potential penalty.

❌ Error 3: Assuming "De Minimis" applies
👉 Consequence: USzyme tests are denied de minimis exemption due to Section 301 and IEEPA. Even small shipments are taxed.

❌ Error 4: Incorrect Labeling (Medical vs. RUO)
👉 Consequence: If labeled "Medical" but no FDA clearance → Refusal of Admission. If labeled "RUO" but sold clinically → Regulatory Violation.

✅ Correct Practice:

"Malaria Rapid Test Cassette (HRP-2/pLDH), In Vitro Diagnostic Device, FDA Cleared, Sterile, Single-Use, Lot No. XYZ, Expiry Date: 2027-12-31"

🎯 VII. Conclusion: Professional Declaration Saves Time, Money, and Headaches!

🎯 Remember the Mantra:

🔹 "Medical Device = 9018, RUO = 3822; 35% Tariff for China, Check FDA Status First!"
🔹 "Labeling is King: 'Diagnostic Use' vs. 'Research Use Only' determines legality!"

📌 Pro Tip:

• If your USzyme tests are manufactured in Vietnam or India, you may avoid the 35% China-specific tariff.
• Verify Country of Origin carefully: Components from China may still trigger "China Origin" rules.
• Apply for an Advance Ruling with CBP to confirm HS Code and duty rate before shipment.

📣 Immediate Action:

📞 Contact a Licensed Customs Broker + Provide FDA 510(k) Summary + Confirm Country of Origin
🚀 Ensure Compliance, Lower Costs, and Smooth Clearance!

✨ Professional Clearance Starts with Accurate Classification!
💼 Every Cent Saved is Profit Gained!